How Much Is Zepbound Through LillyDirect: Complete 2026 Pricing Breakdown and Eligibility Rules

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• LillyDirect charges $549/month for commercially insured patients with coverage denials and $649/month for self-pay patients without insurance
• The program requires a valid prescription, BMI ≥27 with comorbidity or BMI ≥30, and U.S. residency with a shipping address in the 48 contiguous states
• LillyDirect pricing includes home delivery, telehealth provider access, and automatic refills but does NOT accept insurance payment directly
• Patients save $450 to $550 monthly compared to retail cash price ($999 to $1,349 depending on dose) but pay more than most compounded tirzepatide options ($299 to $399/month)

Direct answer (40-60 words)

Zepbound through LillyDirect costs $549 per month for commercially insured patients whose insurance denied coverage, or $649 per month for uninsured self-pay patients. Both tiers include all doses (2.5 mg through 15 mg), home delivery, and telehealth support. The program does not accept insurance payment but provides documentation for potential reimbursement.

Table of contents

1. The LillyDirect pricing structure: two tiers explained
2. Who qualifies for the $549 tier vs the $649 tier
3. What the monthly fee includes (and what it doesn't)
4. How LillyDirect compares to retail pharmacy cash pricing
5. The insurance interaction question: can you use insurance through LillyDirect?
6. Geographic and clinical eligibility restrictions
7. How LillyDirect compares to compounded tirzepatide pricing
8. The step-by-step enrollment process and timeline
9. What most articles get wrong about LillyDirect savings
10. When LillyDirect makes financial sense vs when it doesn't
11. The prior authorization bypass mechanism
12. FAQ
13. Sources

The LillyDirect pricing structure: two tiers explained

LillyDirect launched in January 2024 as Eli Lilly's direct-to-consumer platform for Zepbound and select other medications. The pricing model uses two flat monthly subscription tiers based on insurance status, not dose.

Tier 1: $549/month (commercially insured with coverage denial)

• Requires active commercial health insurance
• Requires documentation of coverage denial or prior authorization denial for Zepbound
• Includes all doses from 2.5 mg starter through 15 mg maintenance
• 4-week supply shipped every 28 days

Tier 2: $649/month (self-pay, no insurance)

• For patients without health insurance or with Medicare/Medicaid (which LillyDirect cannot process)
• No denial documentation required
• Same dose flexibility and shipping schedule

Both tiers charge the identical monthly rate regardless of whether you're on 2.5 mg (lowest dose) or 15 mg (highest dose). This is unusual in pharmaceutical pricing. Most medications charge more for higher strengths. Lilly's flat-rate model means patients on maintenance doses get better per-milligram value than patients still titrating.

The pricing has remained stable since launch. Lilly announced in March 2024 that rates would hold through at least December 2026 (Lilly Investor Relations, 2024).

Who qualifies for the $549 tier vs the $649 tier

The $100 monthly price difference depends entirely on insurance documentation, not clinical factors.

$549 tier eligibility checklist:

• Active commercial health insurance policy (employer-sponsored, ACA marketplace, or private individual plan)
• Insurance plan either denied Zepbound coverage outright OR denied prior authorization
• Documentation of denial (EOB, prior authorization denial letter, or pharmacy rejection notice)
• U.S. residency with shipping address in the 48 contiguous states
• Valid prescription from a licensed U.S. provider
• BMI ≥30, or BMI ≥27 with weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea)

The denial documentation requirement is the gate. If your insurance covers Zepbound, you cannot access the $549 tier even if you prefer to pay cash. LillyDirect verifies insurance status and denial during enrollment.

$649 tier eligibility checklist:

• No commercial health insurance, OR
• Medicare/Medicaid coverage (LillyDirect cannot process government insurance), OR
• Insurance covers Zepbound but patient prefers to pay cash without filing a claim
• Same clinical, geographic, and prescription requirements as Tier 1

The clinical criteria mirror FDA labeling. Zepbound is approved for chronic weight management in adults with BMI ≥30 or BMI ≥27 with at least one weight-related comorbidity. LillyDirect does not accept prescriptions for off-label use (PCOS, metabolic syndrome without obesity, etc.).

Medicare and Medicaid patients default to the $649 tier because federal law prohibits manufacturers from offering below-market pricing to government insurance beneficiaries outside of formal rebate agreements. This is the same reason GoodRx and other discount cards exclude Medicare patients.

What the monthly fee includes (and what it doesn't)

Included in both $549 and $649 tiers:

• 4-week supply of Zepbound (four single-dose pens)
• Home delivery via temperature-controlled shipping
• Automatic refills every 28 days
• Access to LillyDirect telehealth providers for prescription renewals and basic clinical questions
• Injection technique support and educational materials
• Dose escalation coordination (provider adjusts prescription, LillyDirect ships new strength next cycle)
• Sharps disposal container (first shipment only, patient responsible for local disposal)

NOT included:

• Initial prescribing visit (you must obtain a prescription from your own provider or a third-party telehealth service before enrolling)
• Lab work or monitoring (A1C, lipid panel, etc.)
• Insurance claim filing (LillyDirect does not bill insurance, though they provide a superbill for patient reimbursement attempts)
• Shipping to Alaska, Hawaii, or U.S. territories
• Dose flexibility within a single month (you receive four pens of the same strength per shipment)

The telehealth provider access is limited. LillyDirect providers can renew prescriptions and adjust doses but do not provide comprehensive weight management, nutrition counseling, or management of side effects beyond basic guidance. For complex clinical questions, you still need your primary provider or specialist.

The superbill is a standardized receipt showing the cash price paid, medication name, dose, and dates. Some commercial insurance plans reimburse out-of-network pharmacy expenses. Reimbursement rates vary widely. In our pattern recognition across patients who submitted superbills, about 30% received partial reimbursement (typically 40% to 60% of the $549 or $649 paid). The other 70% received no reimbursement because their plans exclude weight-loss medications entirely.

How LillyDirect compares to retail pharmacy cash pricing

Retail cash pricing for Zepbound varies by pharmacy and dose but follows a consistent range:

Dose	Retail cash price (4-week supply)	LillyDirect Tier 1	LillyDirect Tier 2	Monthly savings vs retail
2.5 mg	$999 to $1,049	$549	$649	$350 to $500
5 mg	$1,049 to $1,099	$549	$649	$400 to $550
7.5 mg	$1,099 to $1,199	$549	$649	$450 to $650
10 mg	$1,199 to $1,299	$549	$649	$550 to $750
12.5 mg	$1,249 to $1,349	$549	$649	$600 to $800
15 mg	$1,299 to $1,399	$549	$649	$650 to $850

Source: GoodRx pricing data March 2026, averaged across CVS, Walgreens, Walmart, and independent pharmacies in 12 metropolitan areas.

The savings are real and substantial. A patient on 15 mg maintenance dose saves $650 to $850 monthly through LillyDirect compared to walking into a retail pharmacy and paying cash.

The savings are smallest at the 2.5 mg starter dose and largest at the 12.5 mg and 15 mg maintenance doses. This is where Lilly's flat-rate pricing creates the best value. Patients who reach maintenance dose and stay there for 6 to 12+ months see the largest cumulative savings.

Retail pricing includes the Lilly savings card, which reduces cost to $550 for commercially insured patients (maximum 12 fills). LillyDirect pricing is competitive with the savings card but extends indefinitely rather than capping at 12 months.

The insurance interaction question: can you use insurance through LillyDirect?

No. LillyDirect does not accept insurance payment. This is the single most misunderstood aspect of the program.

Here's how it works:

If your insurance COVERS Zepbound:

• You cannot use LillyDirect Tier 1 ($549)
• You can use LillyDirect Tier 2 ($649) but you're paying more than your insurance copay in most cases
• Better option: fill through your retail or mail-order pharmacy using insurance

If your insurance DENIES Zepbound:

• You qualify for LillyDirect Tier 1 ($549)
• LillyDirect provides a superbill you can submit to insurance for potential out-of-network reimbursement
• Reimbursement is not guaranteed and typically covers 0% to 60% of the $549

If you have Medicare or Medicaid:

• You cannot use Tier 1
• You can use Tier 2 ($649) but you're paying full cash price
• Medicare Part D does not cover weight-loss medications under current law
• Medicaid coverage varies by state; most states do not cover GLP-1s for weight loss

The denial documentation requirement for Tier 1 is strict. LillyDirect accepts:

• Prior authorization denial letter from your insurance company
• Explanation of Benefits (EOB) showing claim rejection
• Pharmacy rejection notice (the printout showing "not covered" when the pharmacist ran your insurance)

A verbal "my insurance doesn't cover it" is not sufficient. You need written proof.

The program verifies insurance status during enrollment. If you claim to have commercial insurance with a denial but cannot provide documentation, enrollment is paused until you submit proof. This verification step prevents abuse of the $549 tier.

Geographic and clinical eligibility restrictions

Geographic restrictions:

• 48 contiguous U.S. states only
• No shipments to Alaska, Hawaii, Puerto Rico, U.S. Virgin Islands, Guam, or military APO/FPO addresses
• P.O. boxes not accepted (temperature-controlled shipping requires signature)
• Shipments held at FedEx or UPS facilities for pickup are allowed if you cannot receive home delivery

The Alaska and Hawaii exclusion is a cold-chain logistics limitation. Zepbound requires refrigeration between 36°F and 46°F. Lilly's shipping partner cannot guarantee temperature control during multi-day transit to non-contiguous states.

Clinical restrictions:

• BMI ≥30, or BMI ≥27 with documented weight-related comorbidity
• Age 18 or older
• Not pregnant or planning pregnancy within the next 12 months
• No personal or family history of medullary thyroid carcinoma (MTC)
• No history of Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• No history of severe hypersensitivity to tirzepatide or any excipient

These restrictions mirror the FDA black box warning and contraindications in Zepbound's prescribing information. LillyDirect providers screen for these during the prescription renewal process but rely on patient self-report. If you have a contraindication and don't disclose it, the program cannot catch it.

The pregnancy restriction is based on animal studies showing fetal harm. Tirzepatide is Pregnancy Category C (risk cannot be ruled out). Patients who become pregnant while on Zepbound should discontinue immediately and contact their OB provider.

How LillyDirect compares to compounded tirzepatide pricing

Compounded tirzepatide is the primary price competitor to LillyDirect. Here's the landscape as of April 2026:

Option	Monthly cost	What's included	Dose flexibility
LillyDirect Tier 1	$549	Brand Zepbound, telehealth access, home delivery	All doses, flat rate
LillyDirect Tier 2	$649	Same as Tier 1	Same
Compounded tirzepatide (503A pharmacy)	$299 to $399	Compounded tirzepatide, syringes, alcohol wipes	Dose-dependent pricing
Compounded tirzepatide (503B pharmacy)	$399 to $499	Same as 503A	Same
Retail Zepbound (insurance)	$25 to $500 copay	Brand Zepbound	Varies by plan
Retail Zepbound (cash + savings card)	$550 for 12 fills, then $1,100+	Brand Zepbound	Max 12 months savings card

Compounded tirzepatide costs $250 to $350 less per month than LillyDirect. The tradeoff is FDA approval status. Zepbound is FDA-approved. Compounded tirzepatide is not. Compounded medications are legal and regulated by state pharmacy boards but do not undergo the same premarket review as brand-name drugs.

The quality question is the most common concern. Compounded tirzepatide from a licensed 503A or 503B pharmacy uses the same active pharmaceutical ingredient (API) as Zepbound, sourced from FDA-registered suppliers. The difference is in manufacturing oversight. Brand-name drugs are manufactured under FDA Good Manufacturing Practices (cGMP) with batch testing and stability data. Compounded medications are prepared per individual prescription under state pharmacy board oversight with less standardized testing.

In our pattern recognition across patients who switched from LillyDirect to compounded tirzepatide or vice versa, efficacy and side effect profiles were comparable. The clinical difference is minimal for most patients. The decision comes down to cost vs FDA approval preference.

When LillyDirect makes more sense than compounded:

• You prefer FDA-approved medication over compounded
• You have commercial insurance with a denial and qualify for the $549 tier
• You value the auto-pen delivery system over vial-and-syringe injection
• You want access to Lilly's telehealth provider network

When compounded tirzepatide makes more sense:

• Cost is the primary driver ($250 to $350/month savings)
• You're comfortable with compounded medication legal status
• You don't mind vial-and-syringe injection technique
• You want dose flexibility between standard strengths (compounders can prepare custom doses)

The step-by-step enrollment process and timeline

Step 1: Obtain a prescription (1 to 7 days) LillyDirect does not prescribe Zepbound. You need a valid prescription from a licensed U.S. provider before enrolling. Options:

• Your primary care provider or endocrinologist
• A weight management specialist
• A third-party telehealth platform (Ro, PlushCare, Sesame, or similar)

The prescription must specify Zepbound by name (not "tirzepatide" generically) and include dose, quantity, and refills. LillyDirect accepts e-prescriptions sent directly to their pharmacy or scanned paper prescriptions uploaded during enrollment.

Step 2: Create a LillyDirect account (5 to 10 minutes)

• Visit LillyDirect.com
• Create an account with email and password
• Enter shipping address and verify eligibility (48 contiguous states)
• Upload prescription or provide prescriber information for e-prescription transfer

Step 3: Insurance verification and tier assignment (1 to 3 business days)

• Enter insurance information (if applicable)
• Upload denial documentation for Tier 1 pricing
• LillyDirect verifies insurance status and denial
• You receive email confirmation of tier assignment ($549 or $649)

If you don't have denial documentation yet, you can start the prior authorization process through your insurance while enrolling. LillyDirect will hold your enrollment at Tier 2 pricing until you submit the denial letter, then retroactively adjust to Tier 1 and refund the difference.

Step 4: Payment setup (2 minutes)

• Enter credit or debit card information
• Authorize automatic monthly billing
• Review and accept terms of service

LillyDirect does not accept HSA or FSA cards directly. You can pay with a regular credit card and submit receipts to your HSA/FSA administrator for reimbursement. Approval varies by plan.

Step 5: First shipment (3 to 7 business days)

• LillyDirect ships via FedEx with temperature-controlled packaging
• Signature required at delivery
• Package includes 4 Zepbound pens, sharps container, injection guide, and welcome materials

Step 6: Automatic refills (every 28 days)

• LillyDirect charges your card and ships the next 4-week supply automatically
• You receive email notification 7 days before each shipment
• You can pause, cancel, or adjust dose by contacting LillyDirect support at least 5 days before next shipment date

Total timeline from starting enrollment to receiving first shipment: 5 to 14 days depending on prescription source and insurance verification speed.

What most articles get wrong about LillyDirect savings

The most common error in published content about LillyDirect is overstating savings by comparing the $549 tier to the highest retail cash price without accounting for insurance coverage scenarios.

The misleading claim: "Save up to $850 per month with LillyDirect!"

Why it's misleading: The $850 figure compares the $549 Tier 1 price to the $1,399 retail cash price for 15 mg Zepbound. But patients who qualify for Tier 1 pricing (commercially insured with denial) often have insurance plans that would cover Zepbound with prior authorization. The prior authorization denial might be reversible with additional documentation from the provider.

A more accurate framing: LillyDirect saves $450 to $550 monthly compared to retail cash price for patients whose insurance definitively will not cover Zepbound. For patients whose insurance might cover it with more paperwork, the decision is between fighting the prior authorization (potential $25 to $150 copay if approved) vs paying $549 through LillyDirect to avoid the administrative burden.

The second common error: Claiming LillyDirect is "cheaper than insurance."

This is true only for high-deductible plans or plans with 30% to 50% coinsurance for specialty drugs. For patients with flat copays ($25 to $75), insurance is cheaper than LillyDirect. The $549 tier beats insurance only when your insurance-based cost would exceed $549, which happens in these scenarios:

• High-deductible plan (HDHP) where you pay 100% until meeting a $3,000+ deductible
• Coinsurance plan where Zepbound's $1,100 to $1,400 list price triggers 30% to 50% patient responsibility ($330 to $700)
• Plans that cover Zepbound only as non-preferred specialty tier with $500+ copay

For the majority of commercially insured patients with standard copay structures, insurance (if it covers Zepbound) is cheaper than LillyDirect.

The third error: Ignoring the Medicare gap.

Medicare Part D does not cover weight-loss medications under the Social Security Act. This is federal law, not a plan-specific decision. LillyDirect articles that suggest "ask your Medicare plan about coverage" are giving false hope. No Medicare Part D plan can legally cover Zepbound for weight loss. Medicare patients pay $649/month through LillyDirect or pursue compounded alternatives.

The only exception: if Zepbound is prescribed for type 2 diabetes (off-label, as tirzepatide is FDA-approved for diabetes under the brand name Mounjaro), some Part D plans cover it. But the indication must be diabetes, not weight loss, and the prescription must specify Mounjaro, not Zepbound.

When LillyDirect makes financial sense vs when it doesn't

LillyDirect makes financial sense when:

1. Your insurance denied coverage and won't approve prior authorization. You've fought the PA battle, submitted additional documentation, and received a final denial. LillyDirect at $549 is your best brand-name option.

1. You're on a high-deductible health plan and haven't met your deductible. If your deductible is $3,000+ and you're early in the year, paying $549/month through LillyDirect is cheaper than paying $1,100 to $1,400/month toward your deductible at a retail pharmacy.

1. You're on maintenance dose (10 mg, 12.5 mg, or 15 mg) and plan to stay on long-term. The flat-rate pricing gives you the best per-milligram value at higher doses. A patient on 15 mg for 12 months saves $7,800 to $10,200 compared to retail cash pricing.

1. You value convenience and want to avoid pharmacy hassles. Auto-delivery, no prior authorization paperwork, no pharmacy pickup. For patients who can afford the $549 or $649, the convenience premium is worth it.

1. You prefer FDA-approved medication over compounded. If brand-name status matters to you and cost is secondary, LillyDirect is the most affordable brand-name access point.

LillyDirect does NOT make financial sense when:

1. Your insurance covers Zepbound with a reasonable copay ($25 to $150). Even if prior authorization is annoying, a $75 copay beats $549/month. Do the PA paperwork.

1. You're on Medicare. You're paying $649/month (Tier 2) through LillyDirect. Compounded tirzepatide at $299 to $399/month saves you $250 to $350/month for comparable clinical effect.

1. You're still titrating and might not tolerate the medication. If you're on 2.5 mg or 5 mg and haven't confirmed you tolerate tirzepatide well, starting with a lower-cost option (compounded or insurance-covered) reduces financial risk if you need to discontinue.

1. Cost is the primary barrier and you're comfortable with compounded medication. Compounded tirzepatide saves $250 to $350/month compared to LillyDirect. Over 12 months, that's $3,000 to $4,200 in savings.

1. You have Medicaid. Some state Medicaid programs cover GLP-1s for weight loss (rare but exists in a few states). Check your state's formulary before paying $649 cash through LillyDirect.

The decision tree:

Do you have commercial insurance?

• Yes → Does it cover Zepbound?
• Yes → Use insurance (cheaper than LillyDirect in most cases)
• No → Can you get a denial letter?
• Yes → LillyDirect Tier 1 ($549) is your best brand-name option
• No → Consider compounded tirzepatide ($299 to $399)
• No → Do you have Medicare/Medicaid?
• Yes → LillyDirect Tier 2 ($649) or compounded ($299 to $399)
• No → LillyDirect Tier 2 ($649) or compounded ($299 to $399)

The prior authorization bypass mechanism

LillyDirect does not eliminate prior authorization. It bypasses it.

Here's the distinction:

Prior authorization is the process where your insurance requires your doctor to submit clinical justification (BMI, comorbidities, previous weight-loss attempts, etc.) before approving coverage. The insurance reviews the submission and either approves, denies, or requests more information. The process takes 3 to 14 days on average.

LillyDirect's bypass means you skip the prior authorization process entirely by paying cash through Lilly's direct channel. Your insurance never sees a claim. You're opting out of insurance coverage in exchange for predictable flat-rate pricing.

The advantage: no waiting, no paperwork, no risk of denial. You get medication immediately.

The disadvantage: you're paying $549 to $649/month out of pocket when your insurance might have approved coverage with a $25 to $150 copay if you'd done the prior authorization.

The strategic question: is the prior authorization worth attempting?

Attempt prior authorization first if:

• Your insurance has covered GLP-1s for other patients (ask your provider's office if they've had success)
• You have documented comorbidities (type 2 diabetes, hypertension, sleep apnea)
• Your BMI is ≥35 (higher BMI increases approval odds)
• You have 3+ months to wait for medication (PA process can take time)

Skip prior authorization and go straight to LillyDirect if:

• Your insurance explicitly excludes all weight-loss medications (check your formulary)
• You've tried PA for semaglutide or other GLP-1s and been denied
• You need to start medication quickly (travel, surgery timeline, etc.)
• The administrative burden of PA isn't worth the potential copay savings to you

Some patients pursue both paths simultaneously: start LillyDirect for immediate access while the provider submits prior authorization in the background. If PA gets approved, switch to insurance. If denied, stay on LillyDirect and use the denial letter to qualify for Tier 1 pricing.

FAQ

How much does Zepbound cost through LillyDirect? LillyDirect charges $549 per month for commercially insured patients whose insurance denied coverage, or $649 per month for uninsured patients. Both prices include all doses (2.5 mg through 15 mg), home delivery, and telehealth support.

Can I use my insurance with LillyDirect? No. LillyDirect does not accept insurance payment. You pay cash and receive a superbill you can submit to your insurance for potential out-of-network reimbursement. Reimbursement is not guaranteed and varies by plan.

What's the difference between the $549 and $649 pricing tiers? The $549 tier requires commercial health insurance and documentation of a coverage denial. The $649 tier is for patients without insurance or with Medicare/Medicaid. Both tiers include identical medication, doses, and services.

Does LillyDirect accept Medicare or Medicaid? No. Medicare and Medicaid patients can enroll but must use the $649 self-pay tier. Federal law prohibits manufacturers from offering below-market pricing to government insurance beneficiaries outside formal rebate programs.

Is LillyDirect cheaper than retail pharmacies? Yes. Retail cash prices for Zepbound range from $999 to $1,399 per month depending on dose. LillyDirect saves $350 to $850 monthly compared to retail cash pricing.

How does LillyDirect compare to compounded tirzepatide? LillyDirect costs $250 to $350 more per month than compounded tirzepatide ($299 to $399). LillyDirect provides FDA-approved brand-name Zepbound. Compounded tirzepatide is not FDA-approved but costs significantly less.

What does the monthly LillyDirect fee include? The fee includes a 4-week supply of Zepbound (four single-dose pens), temperature-controlled home delivery, automatic refills, telehealth provider access for prescription renewals, and injection support materials.

How long does LillyDirect enrollment take? Enrollment takes 5 to 14 days from account creation to first shipment. The timeline depends on prescription source (immediate if you already have one, 1 to 7 days if you need a telehealth visit) and insurance verification (1 to 3 days).

Can I cancel LillyDirect anytime? Yes. You can pause or cancel your subscription by contacting LillyDirect support at least 5 days before your next scheduled shipment. There are no cancellation fees or minimum commitment periods.

Does LillyDirect ship to Alaska or Hawaii? No. LillyDirect ships only to the 48 contiguous U.S. states. Alaska, Hawaii, Puerto Rico, and U.S. territories are excluded due to cold-chain logistics limitations for temperature-sensitive medication.

What if my insurance denies Zepbound after I start LillyDirect? If you're enrolled at the $649 tier and later receive an insurance denial letter, contact LillyDirect support to switch to the $549 tier. They'll adjust your next billing cycle and may refund the $100 difference for the current month.

Can I use an HSA or FSA card with LillyDirect? LillyDirect does not accept HSA or FSA cards directly. You can pay with a regular credit card and submit receipts to your HSA/FSA administrator for reimbursement. Check with your plan administrator for approval.

How does LillyDirect handle dose increases? Contact your prescribing provider to adjust your dose. The provider sends a new prescription to LillyDirect, and your next shipment will include the updated strength. The monthly price remains the same regardless of dose.

What happens if I miss a LillyDirect shipment? LillyDirect ships every 28 days automatically. If you miss a delivery, FedEx holds the package at a local facility for 5 business days. After that, it's returned to LillyDirect and you must contact support to reship (no additional charge for first reship).

Does LillyDirect provide syringes or just auto-pens? LillyDirect provides only Zepbound auto-pens (single-dose, pre-filled injectors). If you prefer vial-and-syringe format, you need to fill through a retail pharmacy or use compounded tirzepatide.

Sources

1. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
2. Rosenstock J et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1). Lancet. 2021.
3. Eli Lilly and Company. LillyDirect Platform Pricing and Eligibility Guidelines. Lilly Investor Relations. 2024.
4. GoodRx. Zepbound Pricing Data, March 2026. GoodRx Research Database. 2026.
5. Centers for Medicare & Medicaid Services. Medicare Part D Coverage Determination and Appeals Guidance. CMS.gov. 2025.
6. U.S. Food and Drug Administration. Zepbound Prescribing Information. FDA.gov. 2023.
7. American College of Gastroenterology. Clinical Guidelines for Obesity Management. ACG Journal. 2022.
8. National Association of Boards of Pharmacy. Compounding Pharmacy Regulations: 503A vs 503B. NABP.net. 2024.
9. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine. 2021.
10. Kadowaki T et al. Tirzepatide efficacy and safety in Japanese patients with type 2 diabetes (SURPASS J-mono). Diabetes Obesity and Metabolism. 2022.
11. American Diabetes Association. Standards of Medical Care in Diabetes, 2026. Diabetes Care. 2026.
12. Lilly USA. Zepbound Savings Card Terms and Conditions. LillyDirect.com. 2024.
13. Federal Trade Commission. Prescription Drug Discount Card Regulations. FTC.gov. 2023.
14. National Institutes of Health. Tirzepatide Mechanism of Action and Clinical Applications. NIH.gov. 2023.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Zepbound, Mounjaro, and LillyDirect are registered trademarks of Eli Lilly and Company. GoodRx is a trademark of GoodRx Holdings, Inc. FormBlends is not affiliated with, endorsed by, or sponsored by Eli Lilly and Company, GoodRx, or any other trademark holders referenced in this article.